Skip to main content
SpringerLink
Log in

Pathology of the Liver Allograft

  • Chapter
Transplantation Pathology

Part of the book series: Current Topics in Pathology ((CT PATHOLOGY,volume 92))

Abstract

Liver transplantation is now a well established and widely used treatment for otherwise incurable liver diseases. Steady improvements in donor organ preservation, surgical techniques and immunosuppressive regimens have reduced the rate of complications and allowed many patients to live long after liver transplantation. Likewise, a wide use of diagnostic liver biopsies has increased the confidence of pathologists in interpreting allograft changes at all stages after surgery. In many instances, histological assessment remains the “gold standard” for diagnosis. Due to an increasing number of active liver-transplantation programs and prolonged patient survival, pathologists working in specialised centres as well as those working in referring hospitals may be confronted with liver-allograft biopsies. Therefore, basic knowledge of this topic is now of clinical and academic importance. In the following account, the various pathological changes that may affect liver allografts are reviewed with an emphasis on diagnostic difficulties.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams DH, Burnett D, Stockley RA, Elias E (1989) Pattern of leucocyte Chemotaxis to bile after liver transplantation. Gastroenterology 97:433–438.

    PubMed  CAS  Google Scholar 

  2. Angus P, Locarnini S, McCaughan G, Jone R, McMillan J, Bowden D (1995) Hepatitis B virus precore mutant infection in association with severe recurrent disease after liver transplantation. Hepatology 21:14–18.

    PubMed  CAS  Google Scholar 

  3. Baddour N, Demetris AJ, Shah G, Tringali R, van Thiel DH (1992) The prevalence, rate of onset and spectrum of histologic liver disease in alcohol abusing liver allograft recipients. Gastroenterology 102: A777.

    Google Scholar 

  4. Balan V, Batts KP, Porayo MK, Krom RAF, Ludwig J, Wiesner RH (1992) Histologic evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology 18: 1392–1398.

    Google Scholar 

  5. Benner KG, Lee R G, Keeffe EB, Lopez RR, Sasaki AW, Pinson CW (1992) Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 103:1307–1312.

    PubMed  CAS  Google Scholar 

  6. Burke GW, Cirocco R, Viciana A, Ruiz P, Markou M, Allouch M, Cianco G, et al. (1996) Early graft loss secondary to massive hemorrhagic necrosis following orthotopic liver trans¬plantation. Evidence for cytokine-mediated univisceral Shwartzman reaction. Transplantation 61: 1370–1376.

    CAS  Google Scholar 

  7. Cakaloglu Y, Devlin J, O’Grady J, Sutherland S, Portmann BC, Tan K-C, Williams R (1995) Importance of concomitant viral infection during late acute liver allograft rejection. Transplantation 59:40–45.

    PubMed  CAS  Google Scholar 

  8. Calne RY, McMaster P, Portmann B, Wall W, Williams R (1977) Observations on preservation, bile drainage and rejection in 64 human orthotopic liver grafts. Ann Surg 186: 282–290.

    PubMed  CAS  Google Scholar 

  9. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Asher NL, et al. (1994) Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 106: 994–999.

    PubMed  CAS  Google Scholar 

  10. Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, Brinster RL (1987) Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 84: 6909–6913.

    PubMed  CAS  Google Scholar 

  11. Cywes R, Mullen M, Stratis M, Greig P, Levy G, Harvey PRC, Strasberg SM (1993). Prediction of the outcome of transplantation in man by platelet adherence in donor liver allografts. Transplantation 56: 316–323.

    PubMed  CAS  Google Scholar 

  12. D’Allessandro A, Kalayoglu M, Sollinger H, Hoffman RM, Reed A, Knechtle SJ, Pirsch JD, et al. (1991) The predictive value of donor liver biopsies for the development of primary dysfunction after orthotopic liver transplantation. Transplantation 51:157–163.

    Google Scholar 

  13. Datta Gupta S, Hudson M, Burroughs AK, Morris R, Amlot P, Scheuer PJ, Dhillon AP (1995). Grading cellular rejection after orthotopic liver transplantation. Hepatology 21:46–57.

    PubMed  CAS  Google Scholar 

  14. Davies HFS, Pollard SG, Calne RY (1989) Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 47: 524–527.

    PubMed  CAS  Google Scholar 

  15. Davies SE, Portmann BC, O’Grady J G, Aldis PM, Chagar K, Alexander GJM, Williams R (1991) Hepatic histological findings after liver transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13:150–157.

    PubMed  CAS  Google Scholar 

  16. Davies SE, Lau JYN, O’Grady JG, Portmann BC, Alexander GJM, Williams R (1992) Evidence that hepatitis D virus needs hepatitis B virus to cause hepatocellular damage. Am J Clin Pathol 98: 554–558.

    PubMed  CAS  Google Scholar 

  17. Demetris AJ, Jaffe R, Sheahan DB, Burnham J, Spero J, Iwatsuki S, Van Thiel, Starzl TE (1986) Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am J Pathol 125:161–172.

    CAS  Google Scholar 

  18. Demetris AJ, Jaffe R, Starzl TE (1987) A review of adult and pediatric posttransplant liver pathology. In: Somers SC (ed) Pathol Annu 2: 347–386.

    Google Scholar 

  19. Demetris AJ, Markus B (1989) Immunopathology of liver transplantation. Crit Rev Immunol 9: 67–92.

    PubMed  CAS  Google Scholar 

  20. Demetris AJ, Fung JJ, Todo S, Banner TB, Zerbe G, Sysyn G, Starzl TE (1990) Pathologic observations in human recipients treated with FK506. Transplant Proc 22 [Suppl 1]: 25–34.

    PubMed  CAS  Google Scholar 

  21. Demetris AJ, Murase N, Nakamura K, Iwaki Y, Yagishashi A, Valdivia L, Todo S, et al. (1992a) Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis 12:51–59.

    PubMed  CAS  Google Scholar 

  22. Demetris AJ, Nakamura K, Yagishashi A, Iwaki Y, Takaya S, Hartman GG, Murase N, et al. (1992b) A clinicopathological study of human allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology 16: 671–682.

    PubMed  CAS  Google Scholar 

  23. Demetris AJ, Seaberg EC, Batts KP, Ferrell L Ludwig J, Markin R, Belle S, et al. (1995) Reliability and predictive value of the NIDDK liver transplant database nomenclature and grading system for cellular rejection of liver allografts. Hepatology 14: 751–755.

    Google Scholar 

  24. Devlin J, Page AC, O’Grady J, Portmann B, Karani J, Williams R (1993) Angiographically determined arteriopathy in liver graft dysfunction and survival. J Hepatol 18: 68–73.

    PubMed  CAS  Google Scholar 

  25. Devlin J, Smith HM, O’Grady JG, Portmann B, Tan K-C, Williams R (1994) Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients. J Hepatol 21: 204–210.

    PubMed  CAS  Google Scholar 

  26. Dietze O, Davies SE, Williams R, Portmann B (1989) Malignant epithelioid haemangio-endothelioma of the liver: a clinicopathological and histochemical study of 12 cases. Histopathology 15: 225–237.

    PubMed  CAS  Google Scholar 

  27. Dmitrewski J, Hubscher SG, Mayer AD, Neuberger J (1996) Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression. J Hepatol 24: 253–257.

    PubMed  CAS  Google Scholar 

  28. Donaldson P, Underhill J, Doherty D Hayllar K, Calne R, Tan K-C, O’Grady J, Wight D, Portmann B, Williams R (1993) Influence of human leukocyte antigen matching on liver allograft survival and rejection: “the dualistic effect”. Hepatology 17:1008–1015.

    PubMed  CAS  Google Scholar 

  29. Doussett B, Hübscher S, Padbury R, Gunson BK, Buckels JA, Mayer AD, Elias E, et al. (1993) Acute liver allograft rejection - is treatment always necessary? Transplantation 55: 529–534.

    Google Scholar 

  30. Dubel L, Farges O, Bismuth H, Sebagh M, Homberg J-C, Johanet C (1995) Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis. J Hepatol 23: 674–80.

    PubMed  CAS  Google Scholar 

  31. Fagan E, Ellis D, Tovey GM, Lloyd G, Smith HM, Portmann B, Tan K-C, et al. (1992) Toga virus-like particles in acute liver failure attributed to sporadic, non-A non-B and recur-rence after liver transplantation. J Med Virol 38: 71–77.

    PubMed  CAS  Google Scholar 

  32. Féray C, Zignego AL, Samuel D, Bismuth A, Reynès M, Tiollais P, Bismuth H, et al. (1990) Persistent hepatitis virus infection of mononuclear cells without concomitant liver infection: the liver transplantation model. Transplantation 49:1155–1158.

    PubMed  Google Scholar 

  33. Féray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, et al. (1994) The course of hepatitis C virus infection after liver transplantation. Hepatology 20: 1137–1143.

    PubMed  Google Scholar 

  34. Ferrell L, Bass N, Roberts J, Ascher N (1992 a) Lipopeliosis: fat induced sinusoidal dilatation in transplanted liver mimicking peliosis hepatis. J Clin Pathol 45: 1109–1110.

    PubMed  CAS  Google Scholar 

  35. Ferrell L, Wright TL, Roberts J, Ascher N, Lake J (1992 b) Hepatitis C viral infection in liver transplant recipients. Hepatology 16: 865–876.

    PubMed  CAS  Google Scholar 

  36. Foster PF, Sankary HN, Hart M, Williams JW, Bhattacharyya A, Coleman J, Ashamann M (1991) Blood and graft eosinophilia as predictors of rejection in human liver transplantation. Transplantation 51: 873–876.

    PubMed  CAS  Google Scholar 

  37. Freese DK, Snover DC, Sharp HL, Gross CR, Savick SK, Payne WD (1991) Chronic rejection after liver transplantation: a study of clinical, histological and immunological features. Hepatology 13: 882–891.

    PubMed  CAS  Google Scholar 

  38. Fried MW, Khudyakov YE, Smallwood GA, Cong M-E, Nichols B, Diaz E, Siefert P, et al. (1997) Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver disease. Hepatology 25:1271–1275.

    PubMed  CAS  Google Scholar 

  39. Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R. (1994) Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology 21: 88–94.

    Google Scholar 

  40. Gane E, Portmann B, Naoumov NV, Smith H, Underhill JA, Donaldson PT, Maertens G, Williams R (1996a) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334:815–820.

    PubMed  CAS  Google Scholar 

  41. Gane EJ, Naoumov NV, Qian K-P, Mondelli M, Maertens G, Portmann BC, Lau JYN, Williams R (1996b) A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 110:167–177.

    PubMed  CAS  Google Scholar 

  42. Gimson AES, Karani J, Heaton ND (1995) Major biliary tract and vascular complications. In: Williams R, Portmann B, Tan K-C (eds) The practice of liver transplantation. Churchill-Livingstone, Edinburgh, pp 199–209.

    Google Scholar 

  43. Gouw ASH, Houthoff HJ, Huitema S, Beelen JM, Gips CH, Poppema S (1987) Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts. Transplantation 43: 291–296.

    PubMed  CAS  Google Scholar 

  44. Gouw ASH, Haagsma EB, Manns M, Klompmaker IJ, Slooff MJH, Gerber M (1994) Is there recurrence of primary biliary cirrhosis after transplantation? A clinicopathologic study in long-term survivors. J Hepatol 20: 500–507.

    PubMed  CAS  Google Scholar 

  45. Greenson JK, Svobodanewman SM, Merion RM, Frank TS (1996) Histologic progression of recurrent hepatitis C in liver transplant allografts. Am J Surg Pathol 20: 731–738.

    PubMed  CAS  Google Scholar 

  46. Gugenheim J, Samuel D, Reynès M, Bismuth H (1990) Liver transplantation across ABO blood group barriers. Lancet 336: 519–523.

    PubMed  CAS  Google Scholar 

  47. Halft G, Todo S, Tzakis AG, Gordon RD, Starzi TE (1990) Liver transplantation for Budd-Chiari syndrome. Ann Surg 211:43–49.

    Google Scholar 

  48. Harrison RF, Davies MH, Neuberger JM, Hübscher SG (1994) Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology 20: 356–361.

    PubMed  CAS  Google Scholar 

  49. Henderson JM, Mackay GJ, Lumsden AB, Atta HM, Brouillard R, Kutner MH (1992) The effect of liver denervation on hepatic haemodynamics during hypovolaemic shock in swine. Hepatology 15:130–133.

    PubMed  CAS  Google Scholar 

  50. Hübscher SG, Adams DH, Buckels JAC, McMaster P, Neuberger J, Elias E (1989) Massive haemorrhagic necrosis of the liver after liver transplantation. J Clin Pathol 42:60–370.

    Google Scholar 

  51. Hübscher SG, Buckels JAC, Elias E, McMaster P, Neuberger J (1991) Vanishing bile-duct syndrome following liver transplantation-Is it reversible? Transplantation 51: 1004–1010.

    PubMed  Google Scholar 

  52. International Panel (1997) Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25: 658–663.

    Google Scholar 

  53. International Working Party (1995) Terminology for hepatic allograft rejection. Hepatology 22:648–654.

    Google Scholar 

  54. Kakizoe S, Yanaga K, Starzl TE, Demetris AJ (1990) Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology 11:932–941.

    PubMed  CAS  Google Scholar 

  55. Kemnitz J, Gubernatis G, Bunzendahl H, Ringe B, Pichlmayr RAG (1989) Criteria for the histopathological classification of liver allograft rejection and their clinical relevance. Transplant Proc 21:2208–2210.

    PubMed  CAS  Google Scholar 

  56. Kerkar N, Hadzic N, Davies ET, Portmann B, Donaldson PT, Rela M, Heaton ND, Vergani D, Mieli-Vergani G (1998) De novo “autoimmune” hepatitis after transplantation Lancet 351: 409–413.

    Google Scholar 

  57. Klintmalm G, Nery J, Husberg B, Gonwa TA, Tillery GW (1989) Rejection in liver transplantation. Hepatology 10: 978–985.

    PubMed  CAS  Google Scholar 

  58. Koskinas J, Portmann B, Lombard M, Smith T, Williams R (1992) Persistent iron overload 4 years after inadvertent transplantation of a heamochromatosis liver in a patient with primary biliary cirrhosis. J Hepatol 16: 351–354.

    PubMed  CAS  Google Scholar 

  59. Langnas AN, Marujo W, Stratta RW, Wood RP, Shaw BW (1991) Vascular complications after liver transplantation. Am J Surg 23: 76–79.

    Google Scholar 

  60. Lautenschlager I, Höckerstedt K, Häyry P (1991) Fine-needle aspiration biopsy in the monitoring of liver allografts. Transpl Int 4: 54–61.

    PubMed  CAS  Google Scholar 

  61. Leon MP, Bassendine MF, Gibbs P, Burt AD, Thick M, Kirby JA (1996) Hepatic allograft rejection: regulation of the immunogenicity of human intrahepatic biliary epithelial cells. Liver Transpl Surg 1: 37–45.

    Google Scholar 

  62. Li S, Stratta RJ, Langnas AN, Wood RP, Marujo W, Shaw BW (1992) Diffuse biliary tract injury after orthotopic liver transplantation. Am J Surg 164: 536–540.

    PubMed  CAS  Google Scholar 

  63. Ludwig J, Wiesner R, Batts K, Perkins JD, Krom RAF (1987) The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 7:476–483.

    PubMed  CAS  Google Scholar 

  64. Ludwig J, Batts KP, MacCarty RL (1992) Ischaemic cholangitis in hepatic allograft. Mayo Clin Proc 67:519–526.

    PubMed  CAS  Google Scholar 

  65. Ludwig J, Batts KP (1994) Transplantation pathology. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC (eds) Pathology of the liver, 3rd edn. Churchill Livingstone, Edinburgh, pp 765–796.

    Google Scholar 

  66. MacDonald GA, Greenson JK, Del Buono EA, Grady WM, Merion RM, Frank TS, Lucey MR, Appleman HD (1997) Mini-microabscess syndrome in liver transplant recipients. Hepatology 26: 192–197.

    PubMed  CAS  Google Scholar 

  67. Marino IR, Todo S, Tzakis A, Klintmalm G, Kelleher M, Iwatsuki S, Starzl TE, Esquivel CO (1988) Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer 62:2079–2084.

    PubMed  CAS  Google Scholar 

  68. Marsh JW, Iwatsuki S, Makowka L, Esquivel CO, Gordon RD, Todo S, Tzakis A, et al. (1988) Orthotopic transplantation for primary sclerosing cholangitis. Ann Surg 207:21–25.

    PubMed  Google Scholar 

  69. Matsumoto Y, McCaughan GW, Painter DM, Bishop A (1993) Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation 56: 69–75.

    PubMed  CAS  Google Scholar 

  70. Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, Irish W, McMichael J, et al. (1997) Weaning immunosuppression in liver transplant recipients. Transplantation 63: 243–249.

    PubMed  CAS  Google Scholar 

  71. McCaughan GW, Davies JS, Waugh JA, Bishop GA, Hall BM, Gallagher ND, Thompson JF, et al. (1990) A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling. Hepatology 12:1305–1313.

    PubMed  CAS  Google Scholar 

  72. McPeake JR, O’Grady JG, Zaman S, Portmann B, Wight DGD, Tan K-C, Calne RY, Williams R. (1993) Liver transplantation for primary hepatocellular carcinoma: tumour size and number determine outcome. J Hepatol 18: 226–234.

    PubMed  CAS  Google Scholar 

  73. McPeake JR, Portmann B (1995) Hepatic malignancy, Budd-Chiai syndrome and space occupying conditions. In: Williams R, Portmann B, Tan K-C (eds) The practice of liver transplantation. Churchill-Livingstone, Edinburgh, pp 57–71.

    Google Scholar 

  74. Michaels MG, Green M, Wald ER, Starzl TE (1992) Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 165:170–174.

    PubMed  CAS  Google Scholar 

  75. Mohamed R, Hubscher SG, Mirza DF, Gunson BK, Mutimer DJ (1997) Posttransplantation chronic hepatitis in fulminant hepatic failure. Hepatology 25:1003–1007.

    PubMed  CAS  Google Scholar 

  76. Mondelli M, Mieli-Vergani G, Alberti A Vergani D, Portmann B, Eddieston ALWF, Williams R (1982) 1982 Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 129: 2773–2778.

    PubMed  CAS  Google Scholar 

  77. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, et al. (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173–192.

    PubMed  CAS  Google Scholar 

  78. Naoumov NV, Alexander GJM, O’Grady JG, Aldis P, Portmann BC, William R (1988) Rapid diagnosis of cytomegalovirus infection by in-situ hybridisation in liver grafts. Lancet 1: 1361–1364.

    PubMed  CAS  Google Scholar 

  79. Neuberger JM, Portmann B, MacDougall B, Calne RY, Williams R (1982) Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 306:1–4.

    PubMed  CAS  Google Scholar 

  80. Neuberger J, Portmann B, Calne R, Williams R (1984) Recurrence of autoimmune chronic active hepatitis following orthotopic liver transplantation. Transplantation 37: 363–365.

    PubMed  CAS  Google Scholar 

  81. Neuberger J (1995) Liver allograft rejection - current concepts on diagnosis and treatment. J Hepatol 23[Suppl 1]: 54–61.

    PubMed  Google Scholar 

  82. Ng IOL, Burroughs AK, Rolles K, Belli LS, Scheuer PJ (1991) Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlation. Histopathology 18: 323–330.

    PubMed  CAS  Google Scholar 

  83. Noack KB, Wiesner RH, Batts K, van Hoek B, Ludwig J (1991) Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical, and histologic evidence for spontaneous resolution. Transplant Proc 23:1448–1451.

    PubMed  CAS  Google Scholar 

  84. O’Grady JG, Alexander GJM, Sutherland S Donaldson PT, Harvey F, Portmann B, Calne RY, Williams R (1988 a) Cytomegalovirus infection and donor/recipient HLA antigens: inter-dependent co-factors in pathogenesis of vanishing bile duct syndrome after transplantation. Lancet 2: 302–305.

    PubMed  Google Scholar 

  85. O’Grady JG, Poison RJ, Rolles K, Calne RY, Williams R (1988 b) Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 207: 373–379.

    PubMed  Google Scholar 

  86. O’Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan K-C, Portmann B, et al. (1992) Hepatitis B reinfection after orthotopic liver transplantation. Serological and clinical implication. J Hepatol 14:104–111.

    Google Scholar 

  87. Oguma S, Belle S, Starzl TE, Demetris AJ (1989) A histometric analysis of chronically rejected human liver allografts: insights into the mechanism of bile duct loss: direct immunologic and ischaemic factors. Hepatology 9: 204–209.

    PubMed  CAS  Google Scholar 

  88. Ottobrelli A, Marzano A, Smedile A, Recchia S, Salizzoni M, Cornu C, Lamy ME, et al. (1991) Patterns of hepatitis Delta virus reinfection and disease in liver transplantation. Gastro enterology 101: 1649–1655.

    CAS  Google Scholar 

  89. Pappo O, Ramos H, Starzl T, Fung J, Demetris A (1995) Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 19:192–206.

    PubMed  CAS  Google Scholar 

  90. Paya C, Holley K, Wiesner RH, Balasubramaniam K, Smith TF, Espy MJ, Ludwig J, et al. (1990) Early diagnosis of CMV hepatitis in liver transplant recipients: role of immuno-staining, DNA hybridisation and culture of liver tissue. Hepatology 12:119–126.

    PubMed  CAS  Google Scholar 

  91. Penn I (1990) Cancers complicating organ transplantation. N Engl J Med 323:1767–1769.

    PubMed  CAS  Google Scholar 

  92. Phillips MJ, Cameron R, Flowers MA, Blendis LM, Greig PD, Wanless I, Sherman M, et al. (1992) Post-transplant recurrent hepatitis B viral disease; viral-burden, steatoviral, and fibroviral hepatitis B.Am J Pathol 40:1295–1308.

    Google Scholar 

  93. Poison R, Portmann B, Neuberger JM, Calne RY, Williams R (1989) Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Gastroenterology 97: 715–725.

    Google Scholar 

  94. Portmann B, Gane E (1995) Use of liver biopsy. In: Williams R, Portmann B, Tan K-C (eds) The practice of liver transplantation. Churchill-Livingstone, Edinburgh, pp 225–241.

    Google Scholar 

  95. Portmann B, Neuberger JM (1995) Disease recurrence (viral and other disorders). In: Wilhams R, Portmann B, Tan K-C (eds) The practice of liver transplantation. Churchill-Livingstone, Edinburgh, pp 245–257.

    Google Scholar 

  96. Portmann B, Neuberger JM, Williams R (1983) Intrahepatic bile duct lesions. In: Calne RY (ed) Liver transplantation. Grune & Stratton, London, pp 279–287.

    Google Scholar 

  97. Portmann B, Wight DGD (1987) Pathology of liver transplantation (excluding rejection). In: Calne RY (ed) Liver transplantation, 2nd edn. Grune and Stratton, London, pp 437–470.

    Google Scholar 

  98. Powell LW (1992) Does transplantation of the liver cure genetic haemochromatosis? J Hepatol 16: 259–261.

    PubMed  CAS  Google Scholar 

  99. Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, et al, (1991) Hepatitis C in patients undergoing liver transplantation. Ann Intern Med 114: 282–284.

    PubMed  CAS  Google Scholar 

  100. Ringe B, Pichlmayr R, Wittekind R, Tusch G (1991) Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 15: 270–285.

    PubMed  CAS  Google Scholar 

  101. Rizzi PM, Kane P, Ryder SD, Ramage JK, Gane E, Tan K-C, Portmann B, Karani J, Williams R (1994) Accuracy of radiology in detection of HCC prior to transplantation: comparison with explanted liver. Gastroenterology 107:1425–1429.

    PubMed  CAS  Google Scholar 

  102. Sallie R, Silva A E, Purdy M, Smith H, McCaustland K, Tibbs C, Portmann B, et al. (1994) Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol 20: 580–588.

    PubMed  CAS  Google Scholar 

  103. Samuel D, Bismuth A, Mathieu D, Arulnaden J-L, Reynès M, Benhamou J-P, Bréchot C, Bismuth H (1991) Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1: 813–815.

    Google Scholar 

  104. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou J-P, Bismuth A and European Concerted Action on Viral Hepatitis (EUROHEP) (1993) Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329: 1842–1847.

    PubMed  CAS  Google Scholar 

  105. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Buckel EG, Steers JL, Wiesner RH, Krom RAF (1993) Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology 17: 605–609.

    PubMed  CAS  Google Scholar 

  106. Saxena R, Tovey DG, Dhawan A, Ellis DDS, Portmann BC (1996) Acute liver failure due to adenovirus hepatitis in a paediatric liver transplant. Int J Surg Pathol 3:189–193.

    Google Scholar 

  107. Schluger LK, Sheiner PA, Thung SN, Lau JYN, Min A, Wolf DC, Fieal I, et al. (1996) Severe cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 23: 971–976.

    PubMed  CAS  Google Scholar 

  108. Sebagh M, Farges O, Kalil A, Samuel D, Bismuth H, Reynes M (1995) Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol 19: 81–90.

    PubMed  CAS  Google Scholar 

  109. Shah G, Demetris AJ, Gavaler JS, Lewis JH, Todo S, Starzi TE, van Thiel DH (1992) Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 103: 323–329.

    PubMed  CAS  Google Scholar 

  110. Sheng R, Campbell WL, Zajko AB, Baron RL (1996) Cholangiographie features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence for recurrent disease. AJR Am J Roengenol 166:1109–1113.

    CAS  Google Scholar 

  111. Slapak GI, Saxena R, Portmann B, Gane E, Calne R, Williams R (1997) Graft and systemic disease in long-term survivors of liver transplantation. Hepatology 25:195–202.

    PubMed  CAS  Google Scholar 

  112. Snover DC, Sibley RK, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher N (1984) Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology 4:1212–1222.

    PubMed  CAS  Google Scholar 

  113. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL (1987) Liver allograft rejection. An analysis of the use of biopsy in determining the outcome of rejection. Am J Surg Pathol 11:1–10.

    CAS  Google Scholar 

  114. Starzi TE, Putnam CW, Hansbrough JF, Porter KA, Reid HAS (1977) Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and technique of secondary duct repair. Surgery 81: 212–221.

    Google Scholar 

  115. Starzi TE, Demetris AJ, Todo S, Kang Y, Tzakis A, Dusquesnoy R, Makowka L, et al. (1989) Evidence for hyperacute rejection of human liver grafts: the case of the canary kidneys. Clin Transpl 3: 37–48.

    Google Scholar 

  116. Starzi TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, Ramos H, et al. (1993) Cell migration and chimerism after whole-organ transplantation. The basis of graft accep¬tance 17:1127–1152.

    Google Scholar 

  117. Steinhoff G, Wonigeit K, Pichlmayr R (1988) Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation 45:394–401.

    PubMed  CAS  Google Scholar 

  118. Stratta RJ, Wood RP, Langnas AN, Hollins RR, Bruder KJ, Donovan JP, Burnett DA, et al. (1989) Diagnosis and treatment of biliary tract complications after orthotopic liver transplantation. Surgery 106: 675–684.

    PubMed  CAS  Google Scholar 

  119. Telenti A, Smith TF, Ludwig J, Ludwig J, Keating MR, Krom RAF, Wiesner RH (1991) Epstein-Barr virus and persistent graft dysfunction after liver transplantation. Hepatology 14: 282–286.

    PubMed  CAS  Google Scholar 

  120. Terrault NA, Wright TL (1997) Leading article. Hepatitis B virus infection and liver transplantation. Gut 40: 568–571.

    CAS  Google Scholar 

  121. Thung SN, Shim K-S, Shieh C, Schwartz M, Theise N, Borcich A, Katz E, et al. (1993) Hepatitis C in liver allografts. Arch Pathol Lab Med 117:145–149.

    PubMed  CAS  Google Scholar 

  122. Todo S, Demetris A, Makowka L, et al. (1989) Primary nonfunction of hepatic allografts with pre-existing fatty infiltration. Transplantation 47: 903–905.

    PubMed  CAS  Google Scholar 

  123. Todo S, Demetris AJ, van Thiel D, Teperman L, Fung J, Starzi TE (1991) Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 13: 619–626.

    PubMed  CAS  Google Scholar 

  124. Torisu M, Yokoyama T, Amemiya H, Kohler PF, Schroter G, Martineau G, Penn I, et al. (1971) Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg 174: 620–639.

    PubMed  CAS  Google Scholar 

  125. Turlin B, Hayllar KM, Slapak Gl, Heaton N, Williams R, Portmann B (1995) Centrilobular necrosis after orthotopic liver transplantation: a longitudinal clinicopathologic study in 71 patients. Liver Transpl Surg 1: 285–289.

    PubMed  CAS  Google Scholar 

  126. Van de Water J, Gerson LB, Ferrell LD, Lake JR, Coppel RL, Batts KP, Wiesner RH, Gershwin ME (1996) Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 24:1079–1084.

    Google Scholar 

  127. Van Hoek B, Wiesner R, Krom R, Ludwig J, Moore SB (1992) Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment and outcome. Semin Liver Dis 12:41–50.

    PubMed  Google Scholar 

  128. Van Thiel DH, Schade RR, Gavaler JS, Shaw BW, Iwatsuki S, Starzi TE (1984) Medical aspects of liver transplantation. Hepatology 4: 79S–83S.

    PubMed  Google Scholar 

  129. Wight DGD, Portmann B (1987) Pathology of liver transplantation. In: Sir Roy Calne (ed) Liver transplantation, 2nd edn. Grune & Stratton, London, pp 385–435.

    Google Scholar 

  130. Williams J, Vera S, Peters T, Van Voorst S, Britt LG, Dean PJ Haggitt R, et al. (1986) Cholestatic jaundice after hepatic transplantation. Am J Surg 151: 65–69.

    PubMed  CAS  Google Scholar 

  131. Wong P, Devlin J, Gane E, Ramage J, Portmann B, Williams R (1993) FK506 rescue therapy for intractable rejection. J Hepatol 17: 284–287.

    PubMed  CAS  Google Scholar 

  132. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, et al. (1992 a) Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 103: 317–322.

    PubMed  CAS  Google Scholar 

  133. Wright HL, Bou-Abboud C, Hassanein T (1992 b) Disease recurrence following liver transplantation for autoimmune chronic active liver disease. Transplantation 53:136–139.

    PubMed  CAS  Google Scholar 

  134. Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzi TE (1991) Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 68: 2095–2100.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. Portmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Koukoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

C. L. Berry

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Portmann, B., Koukoulis, G. (1999). Pathology of the Liver Allograft. In: Berry, C.L. (eds) Transplantation Pathology. Current Topics in Pathology, vol 92. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59877-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59877-7_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64162-6

  • Online ISBN: 978-3-642-59877-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation